Registered Kenya · PPB

CIPROBAY HC OTIC DROPS

CIPROFLOXACINHYDROCORTISONE

What it does

Ciprofloxacin and hydrocortisone is a combination medicine used to treat infections and reduce inflammation.

Commonly used for: ear infections, skin infections, inflammation in the ears or skin

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2007/008
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
CIPROFLOXACINHYDROCORTISONE
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Pan Pharmaceuticals
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
Bunsenstraße 4, 22946 Trittau, Germany

Source: Pharmacy and Poisons Board · fetched 2026-01-28 22:00:37 · updated 2026-03-23 04:45:45

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Ciprofloxacin and hydrocortisone is a combination medicine used to treat infections and reduce inflammation.

What it treats

  • ear infections
  • skin infections
  • inflammation in the ears or skin

How it works

Ciprofloxacin is an antibiotic that fights bacteria, while hydrocortisone is a steroid that helps reduce swelling and irritation.

Who it's for

This medicine is suitable for adults and children with certain types of infections and inflammation.

Cautions

  • • Do not use if you are allergic to ciprofloxacin or hydrocortisone.
  • • Consult your doctor if you have other health conditions or are taking other medications.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: ciprofloxacinhydrocortisone

Ciprofloxacin and hydrocortisone is a combination medication that leverages the antibacterial properties of ciprofloxacin, a fluoroquinolone antibiotic, and the anti-inflammatory effects of hydrocortisone, a corticosteroid. This combination is primarily used in the treatment of infections where inflammation is also a concern, particularly in otic formulations for ear infections and conditions such as otitis externa. The synergistic effect helps to mitigate inflammation while effectively treating bacterial infections.

Indications

  • Otitis externa
  • Bacterial ear infections
  • Inflammatory conditions associated with bacterial infections

Dosage

Children: Refer to the BNF for Children for appropriate dosing based on the child's age and weight.

Adults: Refer to the BNF for specific dosing recommendations based on the condition being treated.

Mechanism of action

Ciprofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, which are essential for bacterial DNA replication, transcription, and repair. This leads to the inhibition of bacterial cell growth and division. Hydrocortisone exerts its effects by binding to glucocorticoid receptors, leading to the modulation of inflammatory responses by inhibiting the release of inflammatory mediators and promoting anti-inflammatory pathways.

Pharmacodynamics

The antibacterial activity of ciprofloxacin is concentration-dependent, meaning that its efficacy increases with higher concentrations relative to the minimum inhibitory concentration (MIC) for the target bacteria. Hydrocortisone reduces inflammation and immune response by decreasing the migration of leukocytes to sites of inflammation and interfering with the function of inflammatory mediators. This combination allows for a reduction in symptoms associated with inflammation alongside effective bacterial eradication.

Pharmacokinetics

Ciprofloxacin is absorbed well following oral administration, with peak plasma concentrations occurring within 1 to 2 hours. It has a bioavailability of about 70%. Ciprofloxacin is widely distributed throughout body tissues and fluids, including the lungs, liver, and kidneys. It is primarily excreted unchanged in the urine. Hydrocortisone also has good bioavailability and is metabolized in the liver, with renal excretion of its metabolites. The half-life of hydrocortisone is approximately 1 to 2 hours, with effects lasting longer due to its anti-inflammatory action.

Contra-indications

  • Hypersensitivity to ciprofloxacin, hydrocortisone, or any of the excipients
  • Viral infections of the ear canal
  • Fungal infections of the ear canal

Adverse effects

  • Local irritation
  • Burning sensation
  • Itching
  • Dryness of the ear
  • Systemic effects may occur with prolonged use

Precautions

  • Use with caution in patients with a history of hypersensitivity reactions
  • Should not be used in patients with perforated tympanic membrane

Pregnancy

Ciprofloxacin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Hydrocortisone is considered safe during pregnancy but should be used judiciously.

Breast-feeding

Ciprofloxacin is excreted in breast milk; caution should be exercised when administering to breastfeeding mothers. Hydrocortisone is also excreted in breast milk but is generally considered safe at therapeutic doses.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Otic solution containing ciprofloxacin 0.3% and hydrocortisone 1%

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.